Clinical Trials

40 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06197438 2024-01-09

Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer

36 enrolled

Stomach Neoplasms

NCT02037048 2024-01-08

FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma

63 enrolled

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT03935256 2023-12-18

Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer

24 enrolled

Neoplasms, Endometrial Neoplasms

NCT05262335 2023-11-28

ALTER-G-001

116 enrolled

Digestive System Neoplasms

NCT00997009 2023-11-14

MITO CERV 2

108 enrolled

Uterine Cervical Neoplasms

NCT04308837 2023-11-14

A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation

29 enrolled

Stomach Neoplasms

NCT03503786 2023-11-13

MITO END-3

125 enrolled

Endometrial Neoplasms

NCT05966441 2023-07-28

Role of Curcumin in Paclitaxel Induced PN

Breast Neoplasms

NCT02560298 2023-06-22

InterAACT

91 enrolled

Anal Canal Carcinoma, Anus Neoplasms

NCT05751265 2023-06-22

Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer

39 enrolled

Stomach Neoplasms

NCT05900921 2023-06-13

Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung Cancer

132 enrolled

Advanced Squamous Non-Small-Cell Lung Cancer

NCT05872412 2023-05-25

Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer

82 enrolled

Triple Negative Breast Neoplasms

NCT05853172 2023-05-10

Surgical Conversion of Candonilimab (AK104) Plus Paclitaxel, S-1 and Apatinib for Unresectable Advanced G/GEJ Cancer

Stomach Neoplasms

NCT03410784 2023-03-24

MITO28MaNGOov4

72 enrolled

Ovarian Neoplasms

NCT05541146 2023-03-23

Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis

GastrointestinalGynecologic

Carcinoma, Peritoneal Neoplasms, Stomach Neoplasms

NCT04638582 2023-03-22

Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)

44 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05749016 2023-03-01

Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer

Locally Advanced Breast Cancer

NCT05749575 2023-03-01

Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer.

28 enrolled

Breast Neoplasms

NCT05741021 2023-02-24

A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

84 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03321188 2023-02-06

Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients

20 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04248998 2023-01-18

BREAKFAST

Triple Negative Breast Neoplasms

NCT05681728 2023-01-12

A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer

26 enrolled

Breast Neoplasms

NCT05214976 2022-12-22

A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients

64 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05627414 2022-11-25

Conversion Therapy of Disitamab Vedotin Combined With Sintilimab and S-1 in HER2 Overexpression Gastric Cancer

Stomach Neoplasms

NCT05574998 2022-10-12

FTANLCNDG

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05522894 2022-08-31

AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC

Esophageal Squamous Cell Carcinoma

NCT05476380 2022-07-27

Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

39 enrolled

Esophageal Neoplasms

NCT05458726 2022-07-26

Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLC

Carcinoma, Non-Small-Cell Lung

NCT05448781 2022-07-07

Recombinant Human Angioendostatin /PD-1 Mab Combined With First-line Chemotherapy in the Treatment of Driver Gene Negative Advanced NSCLC

38 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05158062 2022-04-26

Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer

35 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT05322499 2022-04-11

Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer

Esophageal Squamous Cell Carcinoma

NCT03570437 2022-03-02

COPELIA

124 enrolled

GynecologicSarcoma

Carcinosarcoma, Neoplasms, Endometrial Neoplasms

NCT04808466 2022-02-21

WUHIPEC01

231 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT05241132 2022-02-15

Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary

27 enrolled

Tumor-Agnostic

Neoplasms

NCT05207904 2022-01-26

Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases

41 enrolled

CNS

Brain Neoplasms

NCT01042522 2022-01-25

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

63 enrolled 16 charts

Granulosa cell tumor of the ovary, Ovarian gynandroblastoma, Sertoli-Leydig Cell Tumor

NCT05111444 2021-11-08

Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

65 enrolled

Stomach Neoplasms

NCT04974944 2021-10-01

First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer

172 enrolled

Uterine Cervical Neoplasms

NCT05044728 2021-09-16

Exploration of Immunodynamic Monitoring in the Population Evaluation of Neoadjuvant Chemotherapy Immunotherapy in Patients With Solid Tumors of the Chest.

GastrointestinalThoracic

Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT04238988 2021-08-27

MITO CERV 3

45 enrolled

Locally Advanced Cervical Cancer

NCT04063683 2021-08-24

Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）.

47 enrolled

Esophageal Squamous Cell Carcinoma

NCT05013697 2021-08-19

TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.

48 enrolled

Esophageal Neoplasms

NCT04973904 2021-07-22

Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer

35 enrolled

Uterine Cervical Neoplasms

NCT04946227 2021-06-30

Pembrolizumab and Paclitaxel in Hormone Receptor-positive, hyperMUTATted Metastatic Breast Cancer Identified by Whole exOme sequeNcing ('MUTATION2')

52 enrolled

Breast Neoplasms

NCT04760431 2021-06-02

TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)

120 enrolled

CNS

Brain Neoplasms

NCT01507428 2021-04-29

Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer

138 enrolled

Stage III Lung Non-Small Cell Cancer AJCC v7

NCT03791905 2021-03-23

PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma

216 enrolled

Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT02617849 2021-02-18

Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma